Food Matters Live Podcast · Food Matters Live

Gut health NPD - the claims problem that needs addressing

·33 min·2 clips
Jelena says the real problem is the concept of gut health, not the evidence.
1. Food Matters Live Podcast's episode "Gut health NPD - the claims problem that needs addressing" was recorded live at Food Matters Live in Ascot. 2. Anthony Zahra hosts a panel with Amy from Naked Biotics, Swami from Naturia, and Colette Short as a regulatory consultant and nutritionist. 3. The episode asks how gut-health NPD can move from promising science to claims regulators will accept. 4. Amy says Naked Biotics is a liquid probiotic brand already on the market and is now focusing on children's microbiomes. 5. She frames kids' probiotics as prevention, saying healthy microbiomes early in life can help avoid later gut problems. 6. Swami says Naturia's strongest product concept would combine prebiotics, probiotics, and postbiotics in one food. 7. He says the format has to feel compatible and "good for your digestion" if consumers are going to buy it. 8. Colette Short says the gut-brain axis is the most promising area because it reaches mood, anxiety, and depression as well as the gut. 9. She says the UK is in a strong position to develop that science space. 10. When Anthony Zahra asks about gut-health signs, Amy links sluggish digestion, bloating, poor sleep, stress, and skin changes to gut function. 11. Colette says the science base is still emerging, but the last five years have brought more robust and elegantly designed human trials. 12. She points to double-blind placebo-controlled studies and recent reviews rather than only animal or in vitro data. 13. Swami says the hardest product challenge is turning science into something consumers already recognize as gut-health food, like oats or yogurt. 14. He says drinks are harder because people do not automatically connect a fiber drink with gut health, and not every format can carry enough fiber. 15. Colette argues that companies must design trials around the claim from the start, including the population, the measures, and whether a stratified group is worth the narrower claim. 16. She says those studies are expensive, and internal budget fights often favor packaging or font changes over research. 17. Jelena, after nine years working with EFSA on prebiotics and FDA on other products, argues that the problem is not a lack of evidence but the concept of gut health itself. 18. She says claims built around changing microbiota and then asserting benefits like better sleep or metabolism fail because regulators need a direct cause-and-effect link and better biomarkers. 19. Louise counters that one good study is not enough, that the full weight of evidence matters, and that groups like the Open Innovation Research Clusters, the National Alternative Protein Innovation Centre, the Co-Centre for Sustainable Food Systems, and Innovate UK can de-risk research. 20. The panel closes with practical advice on inulin, calcium, spirulina pills for NASA-style space diets, and consumer education that emphasizes benefits rather than biotics terminology.
Listen to the show on